Randomised, Controlled Study to Assess Safety and Tolerance of Infant Formula With Prebiotics and Postbiotics in Healthy Infants. — WAVE

Healthy Term Infants Clinical Trial

Official title:
A Randomised, Controlled, Double-blind, Parallel Group, Multi-country Study to Investigate the Safety and Tolerance of Infant Formula With Prebiotics and Postbiotics in Healthy Term Infants.

Status Completed

Clinical Trial Summary

A randomised, controlled, double-blind, parallel group, multi-country study to investigate the safety and tolerance of infant formula with prebiotics and postbiotics in healthy term infants.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Healthy Term Infants

Clinical Trial Details

NCT number	NCT04015050
Study type	Interventional
Source	Nutricia Research
Contact
Status	Completed
Phase	N/A
Start date	July 10, 2019
Completion date	December 3, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02646969` - Growth and Metabolic Biomarkers of Healthy Term Infants Fed Formulas With Staged Protein Concentrations Over the First Year of Life	N/A
Terminated	`NCT01137877` - Growth and Tolerance of Healthy Term Infants to a New Infant Formula	Phase 3
Completed	`NCT01155414` - Tolerance of Healthy Term Infants Fed Infant Formulas #4	Phase 3
Completed	`NCT01497314` - Growth and Safety of a Low Lactose Milk-Based Infant Formula	N/A
Terminated	`NCT02221687` - The Combiotic-Study	N/A
Completed	`NCT00712608` - The Evaluation of Cow's Milk Formula - Study B	N/A